Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Use of health information technology (HIT) to improve statin adherence and low-density lipoprotein cholesterol goal attainment in high-risk patients: proceedings from a workshop.

Cohen JD, Aspry KE, Brown AS, Foody JM, Furman R, Jacobson TA, Karalis DG, Kris-Etherton PM, Laforge R, O'Toole MF, Scott RD, Underberg JA, Valuck TB, Willard KE, Ziajka PE, Ito MK.

J Clin Lipidol. 2013 Nov-Dec;7(6):573-609. doi: 10.1016/j.jacl.2013.10.002. Epub 2013 Oct 12.

PMID:
24314357
2.

The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease.

Ho KT, Chin KW, Ng KS, Alemao E, Rajagopalan S, Yin D.

Am J Cardiovasc Drugs. 2006;6(6):383-91.

PMID:
17192128
3.

Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.

Waters DD, Brotons C, Chiang CW, Ferrières J, Foody J, Jukema JW, Santos RD, Verdejo J, Messig M, McPherson R, Seung KB, Tarasenko L; Lipid Treatment Assessment Project 2 Investigators..

Circulation. 2009 Jul 7;120(1):28-34. doi: 10.1161/CIRCULATIONAHA.108.838466. Epub 2009 Jun 22.

5.

The need for a systematic approach to statin switching: an analysis of real-world experience.

Kakavas PW, McManus JL, Wolfe TA, Guidry T, Flores DN, Ter Riet LB, Glover JJ, Sell H.

J Cardiovasc Nurs. 2013 Nov-Dec;28(6):565-72. doi: 10.1097/JCN.0b013e31826fe89d.

PMID:
23064180
6.

Effect of health information technology interventions on lipid management in clinical practice: a systematic review of randomized controlled trials.

Aspry KE, Furman R, Karalis DG, Jacobson TA, Zhang AM, Liptak GS, Cohen JD.

J Clin Lipidol. 2013 Nov-Dec;7(6):546-60. doi: 10.1016/j.jacl.2013.10.004. Epub 2013 Oct 12. Review.

PMID:
24314354
7.

Adherence to statins and LDL-cholesterol goal attainment.

Chi MD, Vansomphone SS, Liu IL, Cheetham C, Green KR, Scott RD, Reynolds K.

Am J Manag Care. 2014 Apr 1;20(4):e105-12.

9.
10.

Lipid management and cholesterol goal attainment in Norway.

Ose L, Skjeldestad FE, Bakken IJ, Levorsen A, Alemao EA, Yin DD, Borgström F, Jönsson L.

Am J Cardiovasc Drugs. 2006;6(2):121-8.

PMID:
16555865
11.
12.

Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.

Bradford WD, Kleit AN, Nietert PJ, Ornstein S.

Clin Ther. 2006 Dec;28(12):2105-18; discussion 2104.

PMID:
17296467
13.

Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study.

Kim HS, Wu Y, Lin SJ, Deerochanawong C, Zambahari R, Zhao L, Zhang Q, Yan P.

Curr Med Res Opin. 2008 Jul;24(7):1951-63. doi: 10.1185/03007990802138731 . Epub 2008 Jun 10.

PMID:
18547466
14.

Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.

Bullano MF, Wertz DA, Yang GW, Kamat S, Borok GM, Gandhi S, McDonough KL, Willey VJ.

Pharmacotherapy. 2006 Apr;26(4):469-78.

PMID:
16553504
15.

Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.

Harley CR, Gandhi SK, Heien H, McDonough K, Nelson SP.

Expert Opin Pharmacother. 2008 Apr;9(5):669-76. doi: 10.1517/14656566.9.5.669.

PMID:
18345946
17.

Lack of goal attainment regarding the low-density lipoprotein cholesterol level in the management of type 2 diabetes mellitus.

Hosokawa M, Hamasaki A, Nagashima K, Harashima S, Toyoda K, Fujita Y, Harada N, Nakahigashi Y, Fujimoto S, Inagaki N.

Intern Med. 2013;52(21):2409-15.

18.

Managing dyslipidemia in the high-risk patient.

Stein EA.

Am J Cardiol. 2002 Mar 7;89(5A):50C-57C. Review.

PMID:
11900720
19.
20.

Supplemental Content

Support Center